Lamotrigine for Absence Seizures
Abstract
The effectiveness and safety of lamotrigine (Lamictal) monotherapy in newly diagnosed typical absence seizures in 45 children and adolescents, aged 3-15 years, were evaluated in a placebo-controlled, double-blind trial at centers in Norfolk, VA; Akron, OH; Boston, MA; and Research Triangle Park, NC.
DOI: https://doi.org/10.15844/pedneurbriefs-13-8-7 | Journal eISSN: 2166-6482
Language: English
Page range: 61 - 61
Published on: Aug 1, 1999
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 1999 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.